Drug Discovery – Development Industry News – Drug Research – Pharmaceutical Business Review #altana #pharma


Posted On Aug 13 2017 by

#pharmaceutical business

#

Drug Discovery & Development

BioLineRx has established a joint venture (JV) with I-Bridge Capital, a Chinese venture capital fund focused on developing innovative therapies in China.
Drug Research Drug Discovery Development News

UK-based biopharmaceutical firm F-star has signed a collaborative agreement with the US start-up Denali Therapeutics to develop a multispecific antibody platform for delivering therapeutics across the blood-brain barrier into the central nervous system (CNS).
Drug Research Drug Discovery Development News

Pfizer has agreed to acquire US biopharmaceutical firm Medivation in a transaction valued at about $14bn.
Drug Research Drug Discovery Development News

DS Biopharma has launched a spin-out company focused solely on fibrotic conditions such as non-alcoholic steatohepatitis (NASH) and pulmonary disorders such as chronic obstructive pulmonary disease (COPD) and Idiopathic pulmonary fibrosis (IPF).
Drug Research Drug Discovery Development News

Hemispherx Biopharma has formed a scientific advisory board (SAB) to leverage its member’s scientific and pharmaceutical expertise and advice to advance the Company’s drug development programs by providing guidance on steering the company forward and capitalizing on business opportunities as well as interactions with the Food and Drug Administration.
Drug Research Drug Discovery Development News

Casebia Therapeutics, the joint venture (JV) between Bayer and gene editing company CRISPR Therapeutics, has commenced its operations in Cambridge, Massachusetts, US.
Drug Research Drug Discovery Development News

Xenetic Biosciences has commenced a collaboration with Excivion to develop a vaccine against Zika and dengue viruses.
Drug Research Drug Discovery Development News

Caribou Biosciences announced that members of its scientific team have discovered that DNA repair outcomes following Cas9 cleavage of DNA are nonrandom and follow highly reproducible patterns for each target site.
Drug Research Drug Discovery Development News

A new study has indicated the Zika virus, which is known to affect unborn babies, may also damage adult brain cells.
Drug Research Drug Discovery Development News

Tioma Therapeutics, a venture-stage biopharmaceutical firm focused on the development of anti-CD47 antibodies to treat solid and hematologic cancers, has raised $86m in Series A venture financing.
Drug Research Drug Discovery Development News

Rhenovia Pharma – Predictive CNS Drug Discovery Development by Biosimulation Using its unique biosimulation platform Rhenovia Pharma offers services and partnerships for pharmacological profiling, target identification and validation, search for synergistic drug combinations, risk assessment for safety and toxicity of drug candidates in the nervous system. Drug Research Drug Discovery Development Suppliers Hybrigenics Services – Protein Interactions Expert Who else knows your protein better than you? Who else knows proteins interactions better than us? Drug Research Drug Discovery Development Suppliers Logopharm – Membrane Proteomics LOGOPHARM GmbH provides specialised services in proteomic target and biomarker R
/* 728×90, создано 05.02.11 */
google_ad_slot = “6127977750”;
google_ad_width = 670;
google_ad_height = 90;
//–>

Last Updated on: August 13th, 2017 at 12:40 am, by


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *